4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Sandoz Group AG (SDZ) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Basel, Switzerland with about 20,000 employees. Its market capitalization is roughly $32 billion. In the fiscal year ended 2025-12-31, SDZ reported $11.2B in revenue and $914M in net income.
Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $11.2B | $10.4B | $10.0B | $9.3B |
| Gross Profit | $5.3B | $4.9B | $4.6B | $4.4B |
| Operating Income (EBIT) | $1.4B | $307M | $375M | $1.2B |
| Net Income | $914M | $0M | $77M | $848M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Dividends Paid | ($315M) | ($215M) | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $22.0B | $19.9B | $19.4B | $17.6B |
| Total Liabilities | $12.6B | $11.7B | $10.8B | $8.8B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SDZ viewer.
About TickerBase · Data methodology & sources · Privacy · Terms